320 related articles for article (PubMed ID: 34731413)
1. Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers.
Chen D; Kelly C; Haw TJ; Lombard JM; Nordman IIC; Croft AJ; Ngo DTM; Sverdlov AL
Curr Heart Fail Rep; 2021 Dec; 18(6):362-377. PubMed ID: 34731413
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular Dysfunction and Chemotherapeutic Agents.
Clasen SC; Wald JW
Curr Cardiol Rep; 2018 Mar; 20(4):20. PubMed ID: 29520629
[TBL] [Abstract][Full Text] [Related]
3. Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues.
Zambelli A; Della Porta MG; Eleuteri E; De Giuli L; Catalano O; Tondini C; Riccardi A
Breast; 2011 Apr; 20(2):176-83. PubMed ID: 21146409
[TBL] [Abstract][Full Text] [Related]
4. HER2+ breast cancer treatment and cardiotoxicity: monitoring and management.
Jerusalem G; Lancellotti P; Kim SB
Breast Cancer Res Treat; 2019 Sep; 177(2):237-250. PubMed ID: 31165940
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
Yu AF; Manrique C; Pun S; Liu JE; Mara E; Fleisher M; Patil S; Jones LW; Steingart RM; Hudis CA; Dang CT
Oncologist; 2016 Apr; 21(4):418-24. PubMed ID: 26984450
[TBL] [Abstract][Full Text] [Related]
6. Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography.
Gkantaifi A; Papadopoulos C; Spyropoulou D; Toumpourleka M; Iliadis G; Kardamakis D; Nikolaou M; Tsoukalas N; Kyrgias G; Tolia M
Anticancer Res; 2019 Apr; 39(4):1667-1673. PubMed ID: 30952705
[TBL] [Abstract][Full Text] [Related]
7. SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.
Lynce F; Barac A; Tan MT; Asch FM; Smith KL; Dang C; Isaacs C; Swain SM
Oncologist; 2017 May; 22(5):518-525. PubMed ID: 28314836
[TBL] [Abstract][Full Text] [Related]
8. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
9. Cardiac imaging in cardiotoxicity: a focus on clinical practice.
Makavos G; Ikonomidis I; Palios J; Rigopoulos A; Katogiannis K; Parissis J; Paraskevaidis I; Noutsias M
Heart Fail Rev; 2021 Sep; 26(5):1175-1187. PubMed ID: 32306221
[TBL] [Abstract][Full Text] [Related]
10. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers.
Nhola LF; Abdelmoneim SS; Villarraga HR; Kohli M; Grothey A; Bordun KA; Cheung M; Best R; Cheung D; Huang R; Barros-Gomes S; Pitz M; Singal PK; Jassal DS; Mulvagh SL
J Am Soc Echocardiogr; 2019 Feb; 32(2):267-276. PubMed ID: 30459123
[TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of novel HER2-targeted therapies.
Sendur MA; Aksoy S; Altundag K
Curr Med Res Opin; 2013 Aug; 29(8):1015-24. PubMed ID: 23692263
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
Gavila J; Seguí MÁ; Calvo L; López T; Alonso JJ; Farto M; Sánchez-de la Rosa R
Clin Transl Oncol; 2017 Jan; 19(1):91-104. PubMed ID: 27101413
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments.
Soltani M; Sokoloff LJ; Fradley MG
Curr Oncol Rep; 2023 Aug; 25(8):923-935. PubMed ID: 37249834
[TBL] [Abstract][Full Text] [Related]
15. Left Ventricular Systolic Dysfunction Predicted By Early Troponin I Release After Anthracycline Based Chemotherapy In Breast Cancer Patients.
Shafi A; Siddiqui N; Imtiaz S; Din Sajid MU
J Ayub Med Coll Abbottabad; 2017; 29(2):266-269. PubMed ID: 28718245
[TBL] [Abstract][Full Text] [Related]
16. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
Akhter N; Murtagh G; Yancy C
Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
[TBL] [Abstract][Full Text] [Related]
17. The utility of cardiac biomarkers and echocardiography for the early detection of bevacizumab- and sunitinib-mediated cardiotoxicity.
Bordun KA; Premecz S; daSilva M; Mandal S; Goyal V; Glavinovic T; Cheung M; Cheung D; White CW; Chaudhary R; Freed DH; Villarraga HR; Herrmann J; Kohli M; Ravandi A; Thliveris J; Pitz M; Singal PK; Mulvagh S; Jassal DS
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H692-701. PubMed ID: 26092985
[TBL] [Abstract][Full Text] [Related]
18. Detecting early onset of anthracyclines-induced cardiotoxicity using a novel panel of biomarkers in West-Virginian population with breast cancer.
Lakhani HV; Pillai SS; Zehra M; Dao B; Tirona MT; Thompson E; Sodhi K
Sci Rep; 2021 Apr; 11(1):7954. PubMed ID: 33846495
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI.
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Neoplasma; 2006; 53(6):511-7. PubMed ID: 17167721
[TBL] [Abstract][Full Text] [Related]
20. Update in imaging of cancer therapy-related cardiac toxicity in adults.
de Baat EC; Naaktgeboren WR; Leiner T; Teske AJ; Habets J; Grotenhuis HB
Open Heart; 2021 Apr; 8(1):. PubMed ID: 33863836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
